UnitedHealth: 3 Key Takeaways for Long-Term Investors

UnitedHealth (UNH) posted Q3 2026 revenue of $113 billion and adjusted EPS of $4.69, and management reiterated its 13-16% long-term growth target.

The print leans on operational execution rather than a single headline surprise. Management pointed to AI-enabled workflow improvements and enterprise reforms as the drivers of momentum. One quantified result stands out: a 30% reduction in prior authorizations, which the company highlighted as evidence the AI integration is producing measurable change.

Commercial client retention also drew emphasis, with the company describing it as strong heading into 2027. Interpretation: retention commentary this far ahead of the new year suggests management wants to frame 2027 as a stable revenue base, though the supplied evidence gives no retention percentage to test that claim.

The reiterated 13-16% growth range is the anchor for the long-term thesis. Holding it, rather than trimming it, signals confidence in the multi-year trajectory. Reiteration is not a raise, so the target alone does not expand the bull case beyond what the market already carried into the print.

The $4.69 adjusted EPS and $113 billion revenue figures give traders concrete benchmarks to compare against their own consensus numbers.